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Abstract
Background: Patients suffering obstructive sleep apnea are mainly treated with continuous positive airway pressure
(CPAP). Although it is a highly effective treatment, compliance with this therapy is problematic to achieve with serious
consequences for the patients’ health. Unfortunately, there is a clear lack of clinical analytical tools to support the early
prediction of compliant patients.
Methods: This work intends to take a further step in this direction by building compliance classifiers with CPAP
therapy at three different moments of the patient follow-up, before the therapy starts (baseline) and at months 1 and
3 after the baseline.
Results: Results of the clinical trial shows that month 3 was the time-point with the most accurate classifier reaching
an f1-score of 87% and 84% in cross-validation and test. At month 1, performances were almost as high as in month 3
with 82% and 84% of f1-score. At baseline, where no information of patients’ CPAP use was given yet, the best
classifier achieved 73% and 76% of f1-score in cross-validation and test set respectively. Subsequent analyzes carried
out with the best classifiers of each time point revealed baseline factors (i.e. headaches, psychological symptoms,
arterial hypertension and EuroQol visual analog scale) closely related to the prediction of compliance independently
of the time-point. In addition, among the variables taken only during the follow-up of the patients, Epworth and the
average nighttime hours were the most important to predict compliance with CPAP.
Conclusions: Best classifiers reported high performances after one month of treatment, being the third month when
significant differences were achieved with respect to the baseline. Four baseline variables were reported relevant for
the prediction of compliance with CPAP at each time-point. Two characteristics more were also highlighted for the
prediction of compliance at months 1 and 3.
Trial registration: ClinicalTrials.gov Identifier, NCT03116958. Retrospectively registered on 17 April 2017.
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Background
Obstructive sleep apnea (OSA) [1] is defined as repeated
episodes of shallow or paused breathing during sleep,
despite the effort to breathe. This syndrome is caused by
complete or partial obstructions of the upper airway lead-
ing to daytime sleepiness and impaired cardiopulmonary
function. Gold standard treatment of OSA involves the
use of a device that administers continuous positive
pressure (CPAP) in the respiratory tract of patients [2].
Patients should wear a mask, usually nasal [3, 4], to receive
the air from the CPAP device. Doctors are responsible for
adjusting the air pressure provided by the device, prevent-
ing the throat from collapsing or damaging its tissue [5].
Several studies aimed at objectively assess the effects
of using CPAP show that this kind of intervention is
highly effective in improving symptoms, such as daytime
sleepiness, morbidity, and mortality rates related to car-
diovascular diseases [6, 7]. Although it is highly effective
in minimizing OSA symptoms, up to 36% of patients do
not use or even discontinue CPAP [8, 9].
Different factors have been found that influence the
adherence to CPAP treatment, although they have not
been reported consistently. In [10] patient demographic
features, such as age, sex, and marital status were found to
be weak predictors of CPAP adherence, as well as apnea-
hypopnea index (AHI), oxygen desaturation index (ODI),
or daytime sleepiness in [11–13]. In contrast, an improve-
ment of ODI and deep sleep in patients during the CPAP
titration increased the chances of complying with CPAP in
[14]. Also, the adherence measured few days after CPAP
initiation was shown to be a good predictor of long-term
compliance in [15].
Despite these efforts, the reasons that lead to compli-
ance with therapy remain an open field of research. In fact,
knowing in more detail the initial factors that determine
compliance with CPAP could help reduce dropout rates
and the application of personalized treatments to improve
patient compliance. Unfortunately, there is a clear lack of
clinical analytical tools to support the early prediction of
compliant patients.
When statistically analyzing the possible factors that
might determine CPAP compliance, we found common
complexities that compromise the predictive capacity and
robustness of the findings. The limited number of par-
ticipants, the large number of clinical variables and the
quality of collected data are just to name a few. To over-
come these limitations the use of machine learning (ML)
might be an alternative solution to the aforementioned
problems. Despite the numerous ML applications in the
medical domain, (e.g. disease diagnosis [16, 17]), compli-
ance with therapy is usually constrained to the medica-
tion adherence problem [18, 19]. Recent ML algorithms
(e.g. support vector machines [20] and artificial neural
networks [21]) often provide highly accurate predictive
models. However, such models lack transparency and
therefore their interpretation is difficult [22]. As a conse-
quence, other classification algorithms in themedical field
are still preferred (e.g. logistic regressions [23] or decision
trees [24]).
The goal of the study presented in this paper is twofold.
On the one hand, to provide a comparative analysis of pre-
dictive methods of CPAP compliance built using machine
learning techniques in different stages of treatment. On
the other hand, to define the most important factors asso-
ciated with CPAP compliance identified by the best pre-
dictive methods obtained in the different stages of therapy
up to month 6.
Methods
Participants
Fifty-one adult patients (> 18 years), diagnosed with OSA
(15 or more apneas/hypopneas per hour in an overnight
sleep study) and requiring CPAP treatment were recruited
at Hospital Arnau de Vilanova (Lleida, Spain). Patients
with impaired lung function (overlap syndrome, obesity
hypoventilation, and restrictive disorders), severe heart
failure, psychiatric disorders, periodic leg movements,
pregnancy, other dyssomnias or parasomnias, and/or a
history of previous CPAP treatment were excluded. The
study was approved by the hospital ethics committee
(Approval number: CEIC-1283). All recruited patients
signed an informed consent form.
Of the 51 patients originally included in the study, 3
were excluded due to malfunction of the CPAP machine,
5 did not attend the last visit at the sleep unit and 1 patient
died during the study.
The final sample consisted of 42 patients (29 males
and 13 females) with a mean age of 56.93+/-12.58 yrs.
Their BMI was 33.83+/-6.46 and their number of apnea
or hypopneas per hour of sleep (apnea/hypopnea index
or AHI) was 53.13+/-20.72 events/h. In our sample, 60%
(25) of all patients were active workers and 33% (14) were
retired. The sample also had 62% of nonsmokers (26) and
57% of non-alcoholic consumers (24). In terms of CPAP
device use, the patients scored an average of nightly hours
of use of 5.44+/-1.74 at month-1, 5.33+/-1.90 at month-3,
5.07+/-2.10 at month-6.
Datasets
The study variables from the 42 patients were manually
collected by lung specialists along four visits at month-0
(baseline or T0), at month-1 (T1), at month-3 (T3), and at
month-6 (T6). During the first visit (T0) clinicians gath-
ered 77 features organized in five categories: clinical his-
tory (e.g. depression, anxiety, arterial hypertension (HTA),
cardiopathy, neurological disease, respiratory disease),
symptoms (e.g. irritability, apathy, depression, insom-
nia), co-morbidities (e.g. diabetes, obesity, dyslipidemia),
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therapies (e.g. beta blockers, diuretics), sleeping test (e.g.
sleeping time, AHI, percentage of the night spent with
oxygen saturation < 90% or CT 90) and basal informa-
tion (e.g. size, weight, BMI, tas, tad, oxygen saturation).
In the second visit (T1), after the patients had the CPAP
machine at home during one consecutive month, 16 new
features related to monitoring were collected (e.g. nightly
average use, abandon or adverse effects of the treatment,
such as dry mouth, allergies, and cutaneous irritations).
At the third month (T3), the same number of features as
in T1 were gathered together with 5 more: size, weight,
BMI, removed drugs, and added drugs). At month-6 (T6),
although some other variables were collected, for the pur-
pose of this study only the average use of nightly hours was
considered. Eventually, three datasets (D0, D1, and D3)
with an incremental number of features (i.e. D1 features
= D0 features + features collected at T1) were created
with 77, 93, and 114 features, respectively. The full list of
variables is described in Additional file 1: Table S1 of the
supplementary material.
In this study, we addressed CPAP compliant users as
those who had more than 4 h per night on average dur-
ing the first 6 months of treatment. Therefore, all samples
from each dataset (ds) were labeled using the collected
information about nightly hours/use on average of the
CPAP device at the end of the month-6. In so doing, 24
(57%) patients were labeled as “compliant”, class “1”, as they
correctly followed the CPAP therapy prescription (more
than 4h nightly on average). On the contrary, 18 (43%)
patients did not achieve the prescribed treatment (minus
or equal than 4 h nightly on average) and they were labeled
as “non-compliant”, class “0”.
Data description
Datasets D0, D1, and D3 collected at time points T0,
T1, and T3, respectively, were statistically analyzed for
a better understanding of the sample. In this task, the
Mann-Whitney U test was used to evaluate the statistical
significance of quantitative variables with CPAP compli-
ance and Chi-square tests for qualitative characteristics.
Previously, the categorical features were converted into
numeric to achieve a homogeneous data type sample.
Variables with only two categories were directly mapped
into binary values. Variables with more than two cate-
gories, given their underlying incremental meaning, were
mapped into unsigned ordinal values.
Data cleansing
We carried out a set of empirical tasks, supervised by the
lung specialists, to reduce possible noise and redundancy
in the datasets. First, given the existence of null values
in the datasets, an imputation process was carried out
consisting of computing themode for the categorical char-
acteristics and the mean for the numerical characteristics.
Subsequently, the distributions of the categorical char-
acteristics were analyzed, which revealed variables with
few individuals by category. The features with a number
of individuals less than a given threshold were removed
from the study to avoid the noise they might introduce
when building the predictive models. To catch up possi-
ble information redundancy in the datasets, we computed
the mutual information (MI) [25] score for the categor-
ical variables in a pair-wise manner. From each pair, we
kept the variable more statistically significant with the
dependent variable using Chi-square test. Among the
numerical features, we applied a correlation analysis to
detect highly redundant features. Given the existence of
non-normally distributed numerical features, we used the
Spearman correlation method on all numerical variables
in a pair-wise manner. Empirically we set-up a thresh-
old for the correlation scores above of which one feature
of the pair was removed (i.e. the feature with the high-
est P-value). P-values lower than 0.05 were considered
statistically significant.
Classification framework
All preprocessed datasets presented common particular-
ities, such as a small number of samples, the presence
of missing values, class unbalance and high multidimen-
sionality feature space. To cope with these complexities
we designed a classification framework flexible enough
to enable the execution of heterogeneous pipelines or
sequence of configurable machine learning steps. In par-
ticular, the pipelines were composed of three mandatory
steps (i.e. imputation, variance filtering and data stan-
dardization), two optional steps (i.e. feature selection and
feature sampling), and two more final steps (i.e. classi-
fier training and evaluation). In total 80 pipelines were
configured from 4 feature selection methods, 5 classi-
fier algorithms, 2 sampling strategies, and 2 evaluation
metrics.
The result of running (i.e. training or building) a pipeline
(Pipei) on a dataset (Dj) with parameters (paramsi) is a
predictivemodel or classifier (Mi,j) with its associated pre-
dictive performance (Perfi,j). Figure 1 sketches the scheme
with the input, output, and the different steps that config-
ure the pipelines for compliance with CPAP therapy.
The first step of a pipeline is the imputation of null val-
ues. To do this, given the small proportion of null values in
the datasets, a simple strategy was proposed to replace the
null values with their most frequent value (for categorical
characteristics) and with the mean value (for numerical
characteristics).
The second step consists of a simple filter method to
eliminate features with zero variance, that is, to elim-
inate these characteristics that have the same value in
all the samples and that do not provide any additional
information to the dataset.
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Fig. 1 Pipeline steps designed for building classifiers for compliance with the CPAP therapy
Since the data come from different sources, the next step
is to standardize them. This step consisted of homoge-
nizing all features to zero mean and variance one. This
transformation step is crucial for the construction ofmany
classification algorithms since it allows them to compare
features without harming their performance or execution
time [26].
Feature selection (fs) was introduced in the pipelines
given a large number of features compared with the num-
ber of samples for each dataset (p > n). This type of
methods aims to reduce over-fitting by improving model
performance and generalization, to provide faster and
more cost-effective models and simplify models making
them easier to interpret [27]. Feature selection methods
are usually divided into three categories: filter, wrapper,
and embedded [28]. Filter methods, in general, examine
features individually with respect to the class, wrapper
methods use a predictive model to generate subsets of fea-
tures evaluated according to their predictive power, and
embedded methods search for an optimal subset of fea-
tures during the training of the prediction model. In this
study, we used one method for each of the different fea-
ture selection strategies. For the filter-based strategy, we
defined a simple method (Combine_fs) that makes a rank-
ing of the features by their statistical significance with the
class (i.e. applying ANOVA or chi-squared tests accord-
ing to the data type of the characteristics). Then, this
method returns the subset of features through a config-
urable threshold. For the wrapper strategy, we proposed
the recursive feature elimination (RFE_RF_fs) method
[29] configured with a random forest to provide the
importance of the features. The embedded strategy was in
charge of the application of the least absolute shrinkage
and selection operator (Lasso_fs) [30]. To this purpose, we
used a logistic regression model configured with the L1
norm. It was also considered the possibility of not using
any method of feature selection.
The next step is data sampling (sm). In particular, we
proposed the use of the synthetic minority over-sampling
technique (Smote) [31]. This technique consists of cre-
ating synthetic samples (i.e. detecting similar instances
and performing small perturbations in their values) of
the under-represented class samples instead of creat-
ing copies, as the over-sampling method would do. In
particular, we used this technique to balance the minority
class with the same number of instances of the major-
ity class. The main idea behind this method is to avoid
the bias produced by many standard classifier learning
algorithms towards the class with a larger number of
instances. As in the feature selection pipeline step, we also
considered the option of not using data sampling in the
experiments.
Regarding the training and evaluation stage, we selected
several classification algorithms (cls) to deal with various
classification strategies (i.e. linear, non-linear, distance-
based, and tree-based). In fact, the provision of different
classification strategies is especially appropriate in com-
plex datasets when the distribution of data is not clear.
As already mentioned, the interpretability of the resulting
predictive models is also a desired condition. Therefore,
we opted for logistic regression (LR) [23], k-nearest neigh-
bor (k-NN) [32], and random forest (RF) [33] for the
subset of interpretable classification algorithms (referred
as “descriptive”, hereinafter). In contrast, we chose sup-
port vector machines (SVM) [20] and artificial neural
networks (NN) [21] for the subset of algorithms with
less interpretative capacity but with a potential greater
discriminatory capacity (referred as “non-descriptive”,
hereinafter).
Evaluation setup
In order to ensure adequate performance evaluation, the
available data were shuffled, stratified, and randomly
divided into train (29 rows, 12 non-compliant, and 17
compliant) and test (13 rows, 6 non-compliant, and 7
compliant) sets with a ratio of 70/30. Therefore, the train-
ing set partitions of the three datasets (D0, D1, and D3)
contained the same individuals. The same rule applies for
the test set.
Test sets remained untouched until the end of the pro-
cess. Training sets were used for 10-fold cross-validation
to enable proper model tuning and evaluation. This tech-
nique is particularly suitable when the sample size is
small. Indeed, as suggested in [34], the entire sequence of
processes that composed each pipeline was wrapped-up
within the cross-validation technique in order to reduce
the possibility of biased results. Thus, training data were
shuffled and randomly split into stratified train-validation
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sets (20 rows, 8 non-compliant, and 12 compliant) and
stratified test-validation sets (9 rows, 4 non-compliant,
and 5 compliant) following a ratio of 70/30. Then, for each
of the configured pipelines (i.e. 80 pipelines), we created
asmany experiments as combinations of values for the dif-
ferent hyper-parameters defined for each method of the
pipeline (Table 1).
We performed 10-fold cross-validation for all experi-
ments in each pipeline. This process was repeated for each
of the proposed learning metrics (i.e. f1-weighted and
precision-weighted). The learning metric, f1-weighted
Table 1 Pipeline parameters tested using grid-search and
10-fold CV
Pipeline step Parameter options
Combine_fs percentile = [5, 10, 20, 30, 40, 50]
Lasso_fs estimator = Logistic Regression
penalty = “l1”
C =[ 5, 10, 20, 30, 40, 50]
RFE_RF_fs class_weight = ‘balanced’
n_estimators = 100
step = [0,1 ]
n_features_to_select = [0.4,0.6,0.8]
Smote_fs n_neighbors = [3,4,5]
ratio=‘auto’
kind=‘regular’
k-NN n_neighbors = [1,3,5,7,9,11]
weights = [‘uniform’, ‘distance’]
LR C = [0.00001, 0.0001, 0.0005, 0.001, 0.005,
0.01, 0.05, 0.1, 0.5, 1, 5, 10, 15, 30]
class_weight = [None, ‘balanced’]
penalty = [‘l1’, ‘l2’]
RF n_estimators = [100,150,200,250,500]
criterion = [‘entropy’,‘gini’]
max_depth = [‘None’,4,6]
class_weight = [None, ‘balanced’]
SVM C = [0.01,0.1,0.5,1,5,10,15,30,50]
gamma = [0.0001,0.001,0.01, 0.1,1,5]
kernel = ‘radial’
class_weight = [None, ’balanced’]
NN alpha = [1e−5, 0.00001, 0.0001, 0.001,
0.01,0.1,1,3,5,10]
hidden_layer_sizes = [(30,), (50,), (70,),
(100,), (150,),
(30,30),(50,50),(70,70),(100,100),
(30,30,30),(50,50,50),(70,70,70)]
(f 1), was selected since it is a suitable measure for
unbalanced datasets. This metric combines the precision
and recall metrics weighted by the number of samples per
each class. The other selected metric, precision-weighted
(prec), tends to prefer classifiers with less incorrect com-
pliant predicted patients, which indeed they are the most
harmful cases to avoid. This metric computes the ratio of
correctly classified cases (i.e. compliant patients) among
all positive classified cases weighted by the number of
samples per each class.
As a result of this 10-fold cross-validation process,
we reported for each experiment the average and stan-
dard deviation performance of the learning metric which
the pipeline was configured with. A greedy-search strat-
egy was applied to select the best experiment, i.e. best
pipeline parameterization. Additionally, with the inten-
tion to avoid the possible bias introduced in this process
to the validation dataset [35] and to reduce the chances
of having obtained similar folds with repeated individ-
uals, we evaluated the best parameterization of each
pipeline (i.e. pipelines with the appropriated values for
their hyper-parameters) using a final outer stratified 10-
fold cross-validation on the training data (i.e. with learn-
ing metric=f1-weighted, ratio=70/30 for cv-train and cv-
test). As a result of this process we reported the final
cross-validation performance (f1-score) of the pipelines.
This score was provided by the f1-weighted metric since
although having a high precision is desirable, a high recall
(rec) is also needed especially for health institutions since
it reduces false negatives and thus non-necessary clinical
interventions and additional costs.
This whole process was repeated 80 times for all
pipelines of each dataset. The best pipelines of each
dataset were identified by ranking the cross-validation
performances (i.e. f1-score) reported by each pipeline.
The best pipelines of each dataset were compared
together in order to find statistically significant differ-
ences. We did the same among the best descriptive and
non-descriptive pipelines. To do this, we used a 10-fold
cross-validated paired t-test.
To complete the reporting of this analysis, we com-
puted on the test set and for each of the best pipelines of
each dataset a comprehensive set of scores (i.e. f1, preci-
sion, recall, AUC, and confusion matrix) to enable a better
understanding of the results. Also, we reported their ROC
and learning curves.
Feature importances
We reported the most important features from the best
descriptive pipelines. Let us note that, in this study, we
only used those configured with random forest and logis-
tic regression. for each dataset. To do this, we performed
a ranking of features using a stability score [36]. This score
measures how “stable” the features of a predictive model
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are. For that reason, we build a pipeline n times using n
random subsets of fixed size s.
To compute this score, we created n = 100 ran-
domly stratified partitions from the s = 70% of the
entire dataset. For each data partition, we trained the best
pipelines and keep a record of the selected features of
the classifier and their weights (or feature importances
for RF classifier). With this information, we computed
the number of times any feature was selected (i.e. sta-
bility score) and its normalized absolute average weight
(or importance). Since one classifier might report all fea-
tures as relevant (i.e. non-zero), a threshold (t > 0.4) in
the weights was empirically defined to make usable the
stability score.
Results
Data cleansing
A descriptive analysis of the initial datasets was car-
ried out and summarized in Tables S2, S3 and S4 of the
Additional file 1. Subsequently, the data cleansing process
was conducted under the supervision of the lung spe-
cialists. From this process, we found out that (11/27/42)
features had null values with ratios between 2.3% and
12% from the total number of rows. After a null imputa-
tion, we found (14/7/10) variables with underrepresented
categories (<= 10% of rows per category). We also
detected 4 pairs of categorical features (i.e. no active,
anti-depressives, ADO, and memory disorders) in the D0
with MI scores above 50%. From the correlation analy-
sis applied on the numerical variables, we found 4 highly
(> 80%) redundant features in D0 (i.e. abdomen and
hip circumference, weight and CT90%) and 4 features in
D3 (i.e. size_3, weight_3, bmi_3 and total_use_hours_3).
After the validation by the specialists of setting aside the
aforementioned features, we obtained the final datasets
for the classification analysis. These were composed of
(54/63/70) variables, respectively.
Classification analysis
We evaluated 76 out of 80 initially configured pipelines
for each dataset. In particular, we rule out pipelines which
had same classification algorithm (i.e. random forest) for
feature selection and classification given their initial poor
contribution to the experimental results and the long
runtime required to complete their evaluation.
Best pipelines (p0, p1, p3) for D0, D1, and D3, respec-
tively, achieved 0.73+/-0.18, 0.82+/-0.06, 0.87+/- 0.15 of
f1-score in cross-validation and 0.76, 0.84, 0.84 in test set
(Table 2). These pipelines were configured with precision-
weighted metric and SVM algorithm for the D0 dataset;
with Smote sampling, f1-weightedmetric, and an SVM for
the D1 dataset, and with Lasso feature selection, Smote
sampling, precision-weighted metric and an RF for the D3
dataset.
To visually support these values, Figs. 2, 3, and 4 show
the area under the receiver operating characteristic (ROC)
curves and Figs. 5, 6, and 7 show the learning curves with
the effects of increasing the size of the training set in their
performances.
We also analyzed which was the contribution in clas-
sification performance of the different techniques con-
figured in the pipelines (i.e. sampling strategy, feature
selection, learning metric, and classification algorithm).
In particular, the average in the performance (i.e. f1-
score) of all pipelines using the sampling strategy was
(0.59+/-0.07,0.61+/-0.09,0.75+/-0.09) for each dataset. Let
us recall that Smote [31] was the selected sampling tech-
nique to balance the training data from each fold of
cross-validation by oversampling the minority class to
the number of samples of the majority class (i.e. from 8
non-compliant/12 compliant to 12/12). On the contrary,
not using any sampling strategy was (0.58+/-0.07,0.62+/-
0.08,0.75+/-0.08). Concerning the average performance
reached among the pipelines configured with the best fea-
ture selection methods they scored (0.59+/-0.03,0.63+/-
0.07,0.77+/-0.08). On the other side, the average in perfor-
mance reached by the pipelines without using any feature
selection gave as result (0.66+/-0.07,0.68+/-0.11,0.77+/-
0.09), respectively. Focusing on the evaluation metric with
which the pipelines were configured, the pipelines with
f1-weighted metric achieved an average in the perfor-
mance of (0.58+/-0.07,0.62+/-0.09,0.76+/-0.09) while the
pipelines configured with precision-weighted obtained an
average performance of (0.59 + / − 0.07, 0.61 + / −
Table 2 Performances of the best pipelines in each dataset
id ds sm fs metric cls params
p0 D0 none none precision_weighted SVM [0.001, balanced, 30]
p1 D1 Smote none f1_weighted SVM [0.001, None, 4, 15]
p3 D3 Smote Lasso_fs precision_weighted RF [1, 250, gini, 4, None, None]
id cv_prec cv_rec cv_f1 test_prec test_rec test_f1
p0 0.78+/-0.2 0.74+/-0.17 0.73+/-0.18 0.77 0.85 0.76
p1 0.84+/-0.06 0.82+/-0.05 0.82+/-0.06 0.85 0.88 0.84
p3 0.89+/-0.14 0.88+/-0.14 0.87+/-0.15 0.85 0.88 0.84
Rafael-Palou et al. BMCMedical Informatics and DecisionMaking  (2018) 18:81 Page 7 of 14
Fig. 2 ROC curves for cross-validation and test of the best pipeline for dataset D0
0.09, 0.75 + / − 0.09). Regarding the type of classification
algorithm (Fig. 8), the best pipelines reported perfor-
mances in cross-validation between 0.59+/-0.21 (using k-
NN) and 0.73+/-0.18 (using SVM) of f1-score in D0. In D1
the best pipelines reported performances between 0.61+/-
0.12 (using k-NN) and 0.82+/-0.06 (with SVM). In D3
the best pipelines reported performances between 0.75+/-
0.07 (using k-NN) and 0.87+/-0.15 (with RF). Table 3
summarizes these differences of performance among the
configured pipelines.
Regarding the comparison of performance between
descriptive and non-descriptive pipelines, the best
descriptive pipelines obtained f1-scores of 0.69 +/-0.15,
0.75 +/- 0.15 and 0.87 +/- 0.15 in cross-validation and
0.76, 0.84, 0.84 in test set, while the best non-descriptive
pipelines obtained scores of 0.73 +/-0.18, 0.82 +/- 0.06 and
0.84 +/- 0.08 in cross-validation and 0.76, 0.84, 0.84 in test
set. Further details about these pipelines can be found in
Table 4.
To complete the analysis, we extracted the most impor-
tant features used by the best descriptive pipelines. In
total (25/28/20) features were reported for each dataset
after setting up a minimum threshold of 0.4 in the feature
weights. Top-10 features of D0 and D1 reported stabil-
ity scores above 0.6. In D3 only 2 features were above 0.4
of stability score. Figures 9, 10, and 11 provides a visual
ranking of the features of each of the dataset ordered by
the stability score.
Fig. 3 ROC curves for cross-validation and test of the best pipeline for dataset D1
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Fig. 4 ROC curves for cross-validation and test of the best pipeline for dataset D3
Discussion
CPAP compliance has been demonstrated to reduce car-
diovascular risk and symptoms in patients with sleep
apnea. Therefore, an automatic support to the early iden-
tification of patients with poor compliance with CPAP
therapy would allow personalized treatments and better
management of hospital resources. Consequently, in this
article we proposed the creation of classifiers that predict
compliance with CPAP therapy in patients with OSA in
the early stages of treatment.
One of the main challenges of this study has been to
build predictive models from small data [37]. In this sce-
nario, models tend to over-fit training and even validation
data, which means they are not able to generalize well for
previously unseen data. To overcome this problem, first,
under the supervision of pulmonary specialists, we per-
formed an initial process of data cleansing to eliminate
the non-relevant and noisy characteristics of the dataset.
Secondly, we set up several machine learning experiments
(e.g. using data sampling, feature selection or one of the
different proposedmachine learning algorithms) to obtain
those with the best generalization performance for each
dataset. To do this, we proposed the use of machine learn-
ing pipelines to carry out all the steps of the learning
experiment together for each of the folds of the cross-
validation. In this way, we avoided the knowledge leakage
Fig. 5 Learning curves of the best pipeline for dataset D0
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Fig. 6 Learning curves of the best pipeline for dataset D1
from the training to the evaluation stage. Thirdly, we used
a nested cross-validation [38] to train, adjust, and evalu-
ate the models. This mechanism reduces the chances of
reporting over-fitted models since the validation scores
are reported through a second level of cross-validation,
once the models are tuned on the first level of cross-
validation. Lastly, we provided a thorough evaluation of
the best models to understand their performance. The
results of this evaluation are presented in Table 2 and
show that the performance of the best predictive models,
both for validation and test datasets, are high (i.e. greater
than 0.7 for D0 and higher than 0.8 for D1 and D3 of preci-
sion, recall, and f1 scores) and close to each other (i.e. with
only 0.02 and 0.03 difference in f1) for each of the analyzed
datasets. These values reflect that current models are reli-
able and generalize well in data partitions that were not
used for training. In addition, as can be seen in the Figs. 5,
6, and 7, validation curves reach the highest values when
all training data are available to build the classifiers. How-
ever, as these are still a bit far from the training curves but
the tendency is to get together, gettingmore data for train-
ing could be beneficial to obtain more accurate models
(especially for datasets D1 and D3).
Going deep into the classification results obtained at
three different moments of CPAP treatment, they show
that dataset D0, collected before the start of treatment,
is the most complex to learn compared to D1 and D3,
collected in months 1 and 3 of the patient’s therapy,
Fig. 7 Learning curves of the best pipeline for dataset D3
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Fig. 8 Best pipelines results in cross-validation and test at different time-points
respectively. Nevertheless, a considerable average f1-score
of 0.73 +/- 0.18 was achieved in cross-validation and 0.76
in the test set. As shown in Table 5, an important per-
formance increase of 0.09 (p = 0.12) was reached in D1
with respect to D0. In D3, we get the best classification
performance with a significant increase of 0.14 in f1-score
(p = 0.024) with respect to D0. This same trend occurred
in the test set where the best pipelines of D1 and D3
reported performances of 0.18 above the achieved in D0.
The difference in f1-score between D3 and D1 did not
prove to be significant (p = 0.30). These results seem
to confirm that follow-up measurements help to increase
baseline prediction performance. Indeed, the closer to the
CPAP compliance cut-off we are the more confident the
classifier is (i.e. performance in D0 is lower than perfor-
mance in D1 and lower than D3). In addition, patterns
of CPAP adherence appear early, in our case at month 1,
since it is when the greatest increase in performance
is achieved. This same finding was confirmed by other
studies [15, 39].
During the evaluation step, we noticed that the use of
sampling, feature selection or a particular learning metric
Table 3 Performance difference of f1 cross-validation along the
different datasets achieved among pipelines configured with
different techniques
D0 D1 D3
Methods Comparisons Avg Max Avg Max Avg Max
Sampling Smote vs None 0.01 -0.02 -0.01 0.04 0.0 0.02
Feature selection Best vs None -0.07 -0.07 -0.05 -0.13 0.0 0.02
Metrics f1 vs prec 0.01 0.02 0.01 0.04 0.01 -0.01
Classifier algorithm Best vs Worst 0.09 0.14 0.14 0.21 0.19 0.20
were not as substantial as expected in any of the datasets
(Table 3). To be more specific, the maximum increase in
performance, regardless of the method used, was between
0.02 and 0.04 of f1-score in cross-validation. Probably this
confined contribution was due to the initial preprocessing
and the fact that the data were not severely unbalanced.
Indeed, in D0 and D1 the use of feature selection com-
promised the performances with a maximum decrease of
0.13. In contrast, important increments of performance in
all datasets were produced depending on the classification
algorithm used (i.e. 0.14, 0.21, and 0.20). In D0 andD1 best
pipelines were using an SVM. This result was not surpris-
ing because this algorithm has been already found suitable
for problems with few samples and with a high number
of features [40], being able to build complex non-linear
decision boundaries. In D3, the best pipeline was config-
ured with an RF, although the one with SVM also provided
a high score. RF algorithm is also suitable for difficult
problems and especially indicated for handling categorical
features [33]. The other non-descriptive classifier (i.e. NN)
reported competent performances in all three datasets,
especially in D3, where it exceeded the results reported
Table 4 Best descriptive and non-descriptive pipelines by dataset
ds sm fs metric cls params
D0 none none prec SVM [0.001, balanced, 30]
D0 Smote none prec LR [None, 15, 4, l2]
D1 Smote none f1 SVM [0.001, None, 4, 15]
D1 none none f1 LR [None, 5, l2]
D3 Smote Lasso_fs prec RF [1, 250, gini, 4, None, None]
D3 none none f1 LR [None, 0.5, l1]
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Fig. 9 Stability scores and feature weights of the best pipeline for dataset D0
by the best pipeline configured with an SVM. However,
the k-NN algorithm reported the worst scores of the three
datasets. This is partly because it does not usually work
well with a large number of features [41].
Focusing on the differences of performance between the
best descriptive and non-descriptive pipelines, those were
always lower than 0.1 and not significant (p = 0.14) for
D0 but significant in D1 (p = 0.02). In contrast, the
best performance in D3 was achieved through a descrip-
tive classifier although in cross-validation the difference
in performance with the best non-descriptive pipeline
(0.02+/-0.16 of f1-score) proved to be non-significant
(p = 0.69).
Regarding the relevant factors related to the CPAP
compliance prediction, four baseline features were found
common in each of the best pipelines for the different
datasets collected at time-points (T0, T1, and T3). Those
were headaches, psychological symptoms (i.e. irritabil-
ity, apathy, and depression), arterial hypertension and the
visual analog scale (as part of EuroQol questionnaire).
From these four features, the headache was the most sta-
ble feature (i.e. with the highest stability score) at T0 and
T1. In the baseline, all these characteristics were found
significant with respect to the CPAP compliance but the
latter (p = 0.079). In particular, compliant patients were
more likely to not having headache (85%, 23 out of 27)
nor psychological symptoms (67%, 18 out of 27), having
arterial hypertension (74%, 20 out of 27) and worst visual
analog scale score (9.15+/-1.02 on mean difference with
respect to non-compliant patients). To the best of our
knowledge, these features together have not previously
been reported as relevant to predict patient compliance
with CPAP therapy at either month 0, 1, and 3. In the
literature, having morning headache was also found sig-
nificant in a randomized control trial of OSA patients
[42]. On the contrary, psychological factors did not show
prediction capability in [43–45] but how patients were
challenging difficult situations (active versus passive) [46].
In [47], authors highlighted the positive effect of CPAP
treatment on blood pressure in patients with resistant
Fig. 10 Stability scores and feature weights of the best pipeline for dataset D1
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Fig. 11 Stability scores and feature weights of the best pipeline for dataset D3
hypertension. The visual analog scale, used as a generic
method for measuring the quality of life, was reported
useful to track treatment-induced changes in [48, 49].
Different studies [50–52] have shown an improvement
in snoring, gastro-esophageal reflux and oxygen satura-
tion with CPAP treatment. In our case, they were found
among the characteristics with the highest stability scores
for the best pipelines of month-0 and month-1. How-
ever, only oxygen saturation (p < 0.001) predicted good
compliance with CPAP.
Two of the features collected at months 1 and 3
(i.e. average hours of nightly CPAP use and Epworth)
were found as the most important predictive features
in these time-points. These features were significant
regarding CPAP compliance. Interestingly, from months
1 to 3 the average of nightly hours of use for com-
pliant users increased (from 5.9+/-1.51 to 6.17+/-1.29)
while in non-compliant users decreased (from 4.4+/-
1.75 to 3.56+/-1.76). On the contrary, the average of
Epworth for compliant users decreased from 5.48+/-3.63
to 4.64+/-3.07, while for non-compliant increased from
7.33+/-3.7 to 8.46+/-4.16). Early measurements of the
average hours of nightly CPAP use were already reported
as predictive of CPAP compliance in [53, 54]. Epworth
was also reported as a relevant predictor of compliance
in [15, 54–56].
Table 5 Performance comparison between best pipelines for
each dataset
Pipelines Difference (cv_f1) Statistic p_value
p0 vs p1 0.09 +/- 0.15 -1.71 0.1201
p0 vs p3 0.14 +/- 0.18 -2.70 0.0241
p1 vs p3 0.05 +/- 0.14 -1.0931 0.3027
The limitations of this study can be summarized in
the following two points. First, although a common cut-
off was selected for the definition of CPAP compliance,
changes in this threshold might cause different perfor-
mances as well as variations in the rank of the feature
importance reported in this work, thus further explo-
rations are required in this regard. Second, despite the
positive scores obtained by the predictive models at the
different time-points, the small number of individuals in
the sample makes it highly recommendable to validate the
obtained results with new data.
Finally, let us point out that the work proposed in this
paper is part of the myOSA project (RTC-2014-3138-1),
aimed at developing new ICT tools to support the OSA
treatment. Under the umbrella of myOSA, we created
an IoT system [57] that remotely monitors the patient’s
CPAP devices to provide indicators of progress such as
early compliance, adherence level, as well as personal-
ized recommendations to empower the patients. More-
over, we are currently investigating how to apply these
predictive methods also in the context of the H2020
project CONNECARE (ID: 689802), in which we focus on
patient’s monitoring with the final goal of providing self-
management features to people in needs, such as chronic
patients [58].
Conclusions
To the best of our knowledge, this article is the first
attempt to analyze and compare the compliance with the
CPAP therapy of patients with OSA at different points of
the treatment by building classifiers. Three time-points
were established to perform the analysis (i.e. before the
treatment starts, at month 1, and atmonth 3). To build and
evaluate the classifiers a flexible framework was designed
relying onmachine learning pipelines. High performances
were reached yet after one month of treatment, being the
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third month when significant differences in performances
were achieved with respect to the baseline. Four base-
line variables were found relevant for the prediction of
compliance with CPAP at each time-point. Two charac-
teristics more, collected during the follow-up, were also
highlighted for the prediction of compliance at months
1 and 3. Further tasks are devised to extend the present
study, including the collection of new patients and explor-
ing other CPAP compliance cut-offs, in order to validate
the findings and reported performances. This work aims
to take a step forward towards the creation of new tools to
allow early and accurate detection of patients struggling to
follow the CPAP treatment and thus enable personalized
patient interventions that would lead to improving their
quality of life.
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